WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

FORMULATION DEVELOPMENT AND EVALUATION OF BILAYER TABLETS CONTAINING ROSUVASTATIN AS IMMEDIATE RELEASE AND METFORMIN HYDROCHLORIDE AS SUSTAINED RELEASE

G. Sundararajan*, P. Stephen, M. Raja and T. Umapoorani

ABSTRACT

The aim of present study is to formulate and evaluate the bilayered tablets containing Rosuvastatin as immediate release (IR) portion and Metformin Hydrochloride as sustained release (SR) portion in order to produce a single tablet containing two different classes of drugs as widely prescribed by doctors and to have better patient compliance. The sustained release layer of Metformin HCl was prepared by using different grades of swellable polymer HPMCK4M and HPMC E3 LV, Ethyl Cellulose by wet granulation method. The Immediate release tablets of Rosuvastatin by wet granulation method using various concentration of sodium starchglycolate as super disintegrant. The powders were evaluated for their flow properties and the finished tablets were evaluated for their physical parameters. The drug release study of Rosuvastatin and Metformin Hydrochloride were evaluated using Type II (Basket) dissolution apparatus under sink condition. The release studies of Rosuvastatin were carried out for 30 minutes by using 900ml of pH 7.4 phosphate buffer was used as dissolution medium at a temperature of 37⁰C ±0.5⁰C. The paddle was stirred at a speed of 100 rpm by using UV- Visible spectrophotometer measured at 354 nm. And for Metformin hydrochloride the release studies were carried out for 10 hours in 900ml of 0.1N HCl was used as dissolution medium for first 2 hours followed by pH 6.8 phosphate buffer solution for next 8 hours maintained at a temperature of 37⁰C ±0.5⁰C. The paddle was stirred at a speed of 100 rpm by using UV-Visible spectrophotometer measured at 233 nm. The release rates of Rosuvastatin from all the formulations were more than 99.74% at the end of 30 minutes. In case of HPMC K4M and HPMC E3 LV, ETHYL CELLULOSE based tablets with the increasing of polymer content the release mechanism moved to super case. Total four trial batches of each drug have been manufactured to optimize and develop a robust and stable formulation, the stability studies of the products also comply with ICH guidelines.

Keywords: Bilayer tablets, Rosuvastatin, Metformin Hydrochloride, HPMC, Sustained release, Immediate release.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More